Columbus, United States
Avation Medical, founded in 2016 and headquartered in the United States, is spearheading innovation in the health care and medical device industries. The company's mission, encapsulated in its slogan, "Avation Medical is making neuromodulation accessible through patient-friendly wearable tech like the NEW Vivally® System," highlights its focus on pioneering user-friendly solutions for complex medical conditions.
Specializing in neuromodulation, Avation Medical developed the Vivally® System, a non-invasive wearable therapy aimed at tackling urinary urgency and incontinence, eliminating the need for traditional surgical interventions. This smart wearable technology underscores the company's commitment to accessible health care advancements through novel medical devices.
The latest financial boost for Avation Medical came via a substantial $22.00M Series C investment closed on 01 February 2024. Esteemed investors like Arboretum Ventures, Avestria Ventures, and Medtronic lend credibility to the company's growth potential and market impact. This backing by a diversified group of investors signals promising confidence in Avation Medical's innovative approach and growth trajectory.
-logo.jpg){kind=logo}
Liv Labs